Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PUMA BIOTECHNOLOGY, INC. Director's Dealing 2015

Aug 27, 2015

33488_dirs_2015-08-27_117d439d-df37-4acc-8a23-75e945ed1781.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2015-08-26

Reporting Person: MOYES JAY M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-26 Stock Option (Right to Buy) $86.43 A 20000 Acquired 2025-08-25 Common Stock (20000) Direct

Footnotes

F1: The vesting commencement date ("VCD") of the option is August 26, 2015. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the VCD and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service through each vesting date as chair of the Audit Committee of the Board of Directors of the Issuer.